In other reports, CXCL2 dose-dependently increases the expression of VEGF within the angiogenic front of tumor margins, thereby promoting tumor angiogenesis, tumor growth and hepatic metastasis in the CXCR2-expressing CT26 CRC cell-induced CRC mice [160,173]. Here, CXCL2 is linked to neoplasm.